Nonalcoholic fatty liver disease (NALFD) is now a leading cause of chronic liver disease
worldwide, in part, as a consequence of rapidly rising levels of obesity and metabolic …

Non-alcoholic fatty liver disease (NAFLD) is an acquired metabolic disease characterized by
triglycerides (TGs) deposition in liver induced by other factors rather than alcohol …

Introduction Non-alcoholic fatty liver disease (NAFLD), a major cause of chronic liver
disease, still lacks effective therapeutic targets today. Ferroptosis, a type of cell death …

Hepatic inflammation is prevalent in several metabolic liver diseases. Recent scientific
advances about the pathogenesis of metabolic liver diseases showed an emerging role of …

Intestinal inflammation is mediated by a subset of cells populating the intestine, such as
enteric glial cells (EGC) and macrophages. Different studies indicate that phytocannabinoids …

Efferocytosis, the phagocytosis of apoptotic cells performed by both specialized phagocytes
(such as macrophages) and non‑specialized phagocytes (such as epithelial cells), is …

Aims The present study aimed to investigate the hepatoprotective effects of Methyl ferulic
acid (MFA) against oxidative stress and apoptosis as well as inflammation in mice with liver …

Aims This study aimed to investigate oxymatrine via regulating miR-182 improved the
hepatic lipid accumulation in non-alcoholic fatty liver disease (NAFLD) model. Materials and …

Evidence from pediatric studies show that infants and children are at risk for early exposure
to microcystin. The present report tests the hypothesis that early life exposure to microcystin …

Prostate cancer is a major health concern in males worldwide, owing to its high incidence.
Sparstolonin B (SsnB), a component of the Chinese herbal medicine Sparganium …